Cardiorespiratory fitness trumps BMI in predicting risk of death and heart disease

As rates of obesity, as defined by body mass index (BMI), continue to climb in the United States, so have efforts to lose weight, including a new era of weight-loss drugs.

The Florida Medical Cannabis Market Is Melting

Each week, Florida’s Office of Medical Marijuana Use (OMMU), which is part of the state’s Department of Health, releases data on the state’s medical cannabis

November 13, 2024

CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK – Biotech Investments

Issuer: CureVac / Key word(s): Study 28.05.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Dosing of

May 29, 2024

Researchers, Doctors, Patients Rally to ‘Stand Up for Science’

“Science saved my life and that is a fact.” That was the message from University of Pennsylvania sophomore Emily Whitehead at the “Stand Up for

March 8, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.